* Instil Bio Inc TIL.OQ reported a quarterly adjusted loss
of 27 cents per share for the quarter ended in June. The mean
expectation of four analysts for the quarter was for a loss
of 20 cents per share.
* Reported revenue was zero; analysts expected zero.
* Instil Bio Inc's reported EPS for the quarter was a loss of 27
cents.
* The mean earnings estimate of analysts had fallen by
about 17.1% in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Instil Bio Inc shares had fallen by 15.8% this quarter.
* The company reported a quarterly loss of $35.31 million.
* Wall Street's median 12-month price target for Instil Bio Inc
is $31.00
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
This summary was machine generated August 12 at 01:00 p.m. All
figures in US dollars unless otherwise stated